Sclerostin
Author
Source
Issue
Vol. 2010, Issue 2010 (31 Dec. 2010), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2010-09-29
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
The striking clinical benefits of intermittent parathyroid hormone in osteoporosis have begun a new era of skeletal anabolic agents.
One potential new agent is monoclonal antibody to sclerostin, a potent inhibitor of osteoblastogenesis.
American Psychological Association (APA)
Silverman, Stuarts L.. 2010. Sclerostin. Journal of Osteoporosis،Vol. 2010, no. 2010, pp.1-3.
https://search.emarefa.net/detail/BIM-510007
Modern Language Association (MLA)
Silverman, Stuarts L.. Sclerostin. Journal of Osteoporosis No. 2010 (2010), pp.1-3.
https://search.emarefa.net/detail/BIM-510007
American Medical Association (AMA)
Silverman, Stuarts L.. Sclerostin. Journal of Osteoporosis. 2010. Vol. 2010, no. 2010, pp.1-3.
https://search.emarefa.net/detail/BIM-510007
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-510007
